CALADRIUS BIOSCIENCES INC (CLBS) Stock Analyst Ratings
NASDAQ:CLBS - Nasdaq - US1280582032 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to CLBS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.59. This target is 976.45% above the current price.
CLBS was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CLBS.
In the previous month the buy percentage consensus was at a similar level.
CLBS was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-03-03 | Brookline Capital | Maintains | Buy |